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1. Introduction 
Living with oxygen is basically unsafe, but vital. During evolution, oxygen originally a 
waste product of the metabolism in primitive unicellular organisms became normal product 
of the metabolism in higher animal species involving humans. Even when oxidative 
reactions are toxic, and destructive, they are tolerated by all organisms to some extent. The 
fact has opened the discussion about efficiency of antioxidant mechanisms.  The classical 
enzyme antioxidant defence alone does not explain high tolerance of the organism for 
oxygen. Moreover, enzyme antioxidant mechanisms are not hundred percent effective in 
preventing oxidation what allows oxidative damage to continue.   
The pathogenesis of autoimmune joint inflammatory diseases is related to activation of 
native immune system. At site of inflammation, activated neutrophils and macrophages 
consume large amounts of oxygen, whose corollary is the increase of reactive oxygen species 
(ROS) production. There are several mechanisms how oxidative stress is involved into the 
pathogenesis of autoimmune joint inflammatory diseases. Excess production of ROS in the 
joint area encourages process of re-oxygenation, which then promotes joint inflammation.  
ROS further inhibit connective tissue cell proliferation, in some cases ROS have been shown 
to induce cell death to these cells inducing apoptosis.  
2. Oxidative stress 
2.1 Biology of oxidative stress 
Cellular responses to oxidative stress depend on the cellular redox status. When the 
oxidants’ level does not exceed the redox capacities in a cell, oxidants are beneficial to the 
cell controlling cellular functions such as signal transduction. In contrast, when the cellular 
antioxidant capacity is insufficient, the production of oxidants exceeds the capacity to 
neutralize them (Hitchon & El- Gabalawy, 2004). Insufficient oxidative defence mechanisms 
shift the balance between oxidants and antioxidants in the direction of oxidants leading to 
oxidative stress. Insufficient oxidative defence mechanisms result from depletion of 
enzymatic (e.g., superoxide dismuthase, catalase, glutathione peroxidase), and non-
enzymatic (e.g., glutathione, vitamins A, C, and E, and selenium) antioxidants (Hovatta et 
al., 2010). The pro-oxidant conditions of the ´internal milieu´, due to low redox status of the 
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cell led to a new definition of oxidative stress. Oxidative stress is defined as ˮ disruption 
between ROS production and elimination leading to their enhanced steady- state in the 
body ˮ (Lushchak, 2011). 
Reactive oxygen species destroy not only intracellular components, but also cell membranes, 
and extracellular components. ROS modify proteins by oxidation, nitrosylation, nitration or 
chlorination of specific amino acids, leading to their impaired biological activity, changes in 
protein structure and accumulation of damaged proteins in the tissue. During lipid 
peroxidation, which is a marker of oxidative stress, polyunsaturated fatty lipids are oxidized 
and produce lipid peroxyl radicals that in turn up-regulate oxidation, and cell membrane 
damage (Hitchon & El- Gabalawy, 2004). Genotoxic effects of oxidative stress involve direct 
breakage of DNA and DNA repair mechanisms. Oxidative stress may also cause cell death. 
Cellular content containing oxidized molecules when released into the extracellular 
environment may contribute to the exacerbation of synovial inflammation as newly formed 
ROS and degradation products form a vicious inflammatory circle (Henrontin et al., 2003).  
3. Reactive oxidant species 
Free radicals are very reactive chemical species that have unpaired valence shell electrons in 
their outer orbitals (Afonso et al., 2007). Highly reactive and partly reduced oxygen 
metabolites are a by-product of oxidative phosphorylation process, which takes part in 
mitochondria. These metabolites called ROS include oxygen radicals [superoxide (O2_), 
hydroxyl (HO), peroxyl (O2R), and alkoxyl (OR)] and certain non radicals that are either 
oxidizing agents or are easily converted into radicals, such as hypochlorous acid (HOCl), 
ozone (O3), singlet oxygen (1O2), and hydrogen peroxide (H2O2). Other oxidants, generated 
by interactions with these molecules, include reactive nitrogen species (RNS), as an example 
nitric oxide (NO), peroxynitrite (ONOO-). 
3.1 Generation of reactive oxidant species 
Generation of ROS is generally cascade of reactions that starts with the production of O2_. 
Superoxide rapidly dismutates to H2O2 either spontaneously, particularly at low pH, or 
catalyzed by superoxide dismutase (SOD) enzyme. Other steps in the cascade of ROS 
generation include the reaction of O2_ with ON to form ONOO -, the peroxidase-catalyzed 
formation of HOCl from H2O2, and the iron-catalyzed Fenton reaction leading to the 
generation of HO. Hydroxyl radical is one of the most reactive oxygen radicals. In biologic 
systems, the HO is formed by the reaction between H2O2 and iron or copper in a low 
valence state. The oxidized halogens are almost as diverse group of reactive oxidants as are 
the free radicals. They consist of HOCl and the vast number of chloramines. Chloramines 
can be produced from the reaction of HOCl with the many amines that are found in 
biological systems. Like HOCl, the chloramines are oxidizing species. Chloramine (NH2Cl) 
is formed by the reaction of HOCl with ammonia (NH3). The reaction of HOCl with amino 
acids leads through chloramines to aldehydes. Altogether, the oxidized halogens represent 
probably the most important microbicidal oxidants produced by neutrophils. Oxygen (O2) 
alone is a diradical with two unpaired electrons. There is also a much more reactive form of 
oxygen known as 1O2, in which those two electrons are paired. The 1O2 is produced by 
neutrophils, which manufacture it by the reaction between H2O2 and an oxidized halogen. 
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Reactive nitrogen species are produced by phagocytes during the reaction of NO with O2_, 
and other oxidizing species. The first characterized of these species is ONOO-, formed in a 
reaction between ON and O2_  , both of which are free radicals. Peroxynitrite then 
undergoes a secondary reaction to produce an agent that is able to nitrate tyrosine. The 
precise composition of the agent is not known, but several candidates have been proposed. 
Among them are various derivatives of ONOO-. Major cellular sites of ROS generation 
include the mitochondria, and non- mitochondrial membrane bound enzyme systems 
(Babior, 2000). 
3.2 Reactive oxidant species in the joint tissue 
Articular cartilage is a unique tissue for its constituent cells, the chondrocytes, which 
maintain the cartilage matrix through their continual synthesis and degradation. The 
environment is avascular, hyperosmotic and acidic. Cartilage cells are synoviocytes, and 
chondrocytes. Chondrocytes display a metabolism adapted to anaerobic conditions. 
Synoviocytes supply the avascular cartilage tissue with nutrients via synovial fluid.  Because 
cartilage is an avascular environment, the oxygen tension in the area is usually low. In 
pathological conditions, like inflammation, oxygen tension is subject of fluctuations. These 
variations of oxygen tension force chondrocytes to produce reactive species. The main 
reactive species produced by chondrocytes are O2_ radical, and NO that generate other 
derivative radicals, including ONOO- and H2O2 (Hiran et al., 1997; Stefanovic- Racic et al., 
1997). The effects of free radicals on articular cartilage are dual. "Chondrocyte- derived" free 
radical levels are important for the maintenance of ion homeostasis. Natrium hydrogen (Na+ 
- H+) - exchanger (NHE- activity) and free radical levels exhibit a significant positive 
correlation. How exactly highly reactive species alter ion transport is not known, although 
interference with protein phosphorylation is possible (Gibson et al., 2008).  
Except beneficial effect free radicals may have on articular cartilage when exceed in a cell, 
free radicals damage both chondrocytes, and extracellular matrix (ECM) components of 
articular cartilage. Free radicals shift the redox balance in articular cartilage in direction of 
oxidants. Hypochlorous acid, singlet oxygen, and peroxynitrite radicals balance the 
ascorbate, an antioxidant vitamin, from cartilage (Hajdigogos et al., 2003).  
ROS and RNS damage articular cartilage directly or indirectly by up- regulating the 
mediators of the ECM degradation. Reactive oxygen/ nitrogen species, e.g. ONOO-, also 
have been shown to degrade aggrecan, a major component of ECM, and this degradation is 
one of the initial events in the process of cartilage destruction (Billinghurst et al., 1997). The 
incidence of sulfated glycosaminoglycans (GAGs) reflects the ratio of aggrecan degradation 
in the cartilage.  
In seeking for a role of oxidative radicals in cartilage metabolism, it has been noted that 
endogenously generated NO suppresses the biosynthesis of aggrecan, a major 
macromolecular component of the cartilaginous matrix (Cao et al., 1997). Furthermore, it 
was discovered that oxygen radicals fragment hyaluronan and chondroitin sulphate 
(Kennett & Davies, 2009).  
Collagen, which provides tensile strength and forms a network that resists the swelling 
pressure of aggrecan- hyaluronate aggregates, can be altered directly by oxygen radicals. 
Free radicals prime collagen to proteolytic enzymes. Incubation of cartilage slices with 
www.intechopen.com
 
Oxidative Stress and Diseases 
 
440 
xanthine-oxidase- generated O2_ anion degrades type I collagen and fibril formation by this 
collagen. Hydroxyl radical in the presence of oxygen fragments collagen into small peptides. 
The cleavage seems to be specific to proline or 4- hydroxyproline residues (Monboisse & 
Borel, 1992). Interestingly, free radicals may destruct collagen synthesis indirectly. NO 
inhibits collagen synthesis via interleukin-1 (IL-1) (Cao et al., 1997). H2O2 inhibits cartilage 
proteoglycan synthesis interfering with adenosine triphosphate (ATP) synthesis, in part by 
inhibiting the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase in 
chondrocytes. ONOO- and HOCl may facilitate cartilage damage by inactivating tissue 
inhibitor of metalloproteinases (TIMPs). TIMP-1 inhibits stromelysins, collagenases and 
gelatinases (Henrontin et al., 2003). Moreover it was observed, that treatment of 
chondrocytes with the NO-producing agent, S-nitroso-N-acetylpenicillamine, up- regulates 
the collagenase mRNA levels, which is one of MMPs (Lo et al., 1998). 
Exposure of the chondrocytes to H2O2 inhibits proteoglycan synthesis (Henrontin et al., 
2003). Chondrocytes in arthritic cartilage respond poorly to insulin- like growth factor 1 
(IGF-1) what may lead to abrogation of cartilage repair. In this context, ROS may participate 
in reducing the capacity of chondrogenic precursor cells to migrate and proliferate within 
joint area. Nitric oxide radical was also demonstrated to inhibit chondrocyte migration and 
attachment to fibronectin via modification of the actin cytoskeleton. Chondrocytes produce 
high levels of NO, which is a mediator of anti- proliferative effects of IL-1 in these articular 
cells (Blanco  Lotz, 1994). In addition, it was discovered that IL-1 induces apoptosis to 
chondrocytes via NO.  Combination of IL-1 with the radical scavengers like N-acetyl 
cysteine, dimethyl sulfoxide, or 5, 5'-dimetylpyrroline 1-oxide induced apoptosis, which was 
inhibited in a dose dependent manner by the NO synthase inhibitor N-monomethyl L-
arginine (Blanco et al., 1995). Chondrocyte death, determined as the percentage of empty 
lacunae in articular cartilage, was completely blocked in p47phox-/- mice confirming the 
“Nicotinamide adenine dinucleotide phosphate” (NADPH)- oxidaseˮ driven oxygen radical 
production in mediating these effects (Lem van Lent et al., 2005). 
Synoviocytes are the second kind of articular cells. These cells consume larger amount of 
oxygen when compared to chondrocytes (Schneider et al., 2005). An indirect evidence of 
oxidative stress in synoviocytes is the incidence of antioxidant enzymes such as superoxide 
dismutase, glutathione peroxidase and catalase in these cells (Mattey et al., 1993). Oxidative 
stress makes synoviocytes to undergo a cell death of an apoptotic nature (Galleron et al., 
1999). The ROS scavenger system of synoviocytes protects chondrocytes from toxic effects of 
free radicals. In a co-culture of these cells synoviocytes reduced toxic effects of H2O2 on 
chondrocyte cell damage (Kurz et al., 1999).  NO is the primary inducer of apoptosis in 
human articular chondrocytes (Blanco et al., 1995). NO- mediated chondrocyte cell death 
requires generation of additional reactive species like ONOO- and O2.-  (Del Carlo Jr. & 
Loeser, 2002).  
Joint fluid is produced as a transudate of plasma from synovial cells and provides nutrition 
to the articular cartilage by diffusion of oxygen and other molecules. The primary catalytic 
antioxidant of the joint fluid is the extracellular SOD (Regan et al., 2008). SOD type III 
accounts for 80% of the enzyme’s activity in the joint fluid (Afonso et al., 2007). 
Glycosaminoglycans (long-chain polysaccharides) are major components of the extracellular 
matrix, glycocalyx, and synovial fluid. Modifications to these materials are linked to 
multiple human pathologies including autoimmune diseases. Hyaluronan and chondroitin 
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sulfate are extensively depolymerized by hydroxyl and carbonyl radicals, which may be 
formed from ONOO-. Polymer fragmentation is shown to be dependent on the radical flux 
(Kennett & Davies, 2009). NO, and O2.- inhibit type II collagen and proteoglycans synthesis 
and the sulfation of newly synthesized GaGs (Hickery & Bayliss, 1998).  
4. Inflammatory synovitis: May oxidative stress be a cause? 
4.1 ROS in inflammatory synovium 
In autoimmune joint diseases systemic inflammation exists long before it exerts local effects on 
synovial membrane. At one point, systemic inflammation is translocated into synovium where 
it initiates the inflammatory response often leading to oxidative burst. Oxidative burst in 
rheumatoid joints is a result of the activation of innate immune system cells. Activated 
phagocytic cells such as neutrophils, and macrophages both produce free radicals in the joint 
area. Activated phagocytes produce reactive oxidants by enzymes: the NADPH- oxidase, and 
the nitric oxide synthase (NOS). Mechanism of free radicals production differs between these 
cell groups. While macrophages are stimulated by the ˮNADPH- oxidaseˮ system to produce 
free radicals, the presence of NOS accompanied by the NADPH- oxidase is necessary for 
neutrophils to secrete free radicals. RA neutrophils also generate enhanced amount of ONOO- 
by NOS (El Benna et al., 2002). Chemiluminescence assays demonstrated significant activation 
of the neutrophil myeloperoxidase H2O2 system in synovial fluids from patients with RA 
further suggesting that oxidative stress may contribute to the cyclic, self- perpetuating nature 
of rheumatoid inflammation. ROS, produced by activated phagocytes alters the antigenic 
behaviour of immunoglobulin G (IgG). Radical-exposed IgG is able to bind rheumatoid factor 
and results in the generation of C3alpha complement component. This reaction may be self-
perpetuating within the rheumatoid joint, suggesting that free radicals play a role in the 
chronicity of rheumatoid inflammation (Newkirk et al., 2002). 
Pro-inflammatory cytokines´ presence and activity undoubtedly subjects to rheumatoid 
synovitis governing a variety of pathological processes including cell activation, cell 
proliferation, tissue resorption and chemotaxis (Schett et al., 2000). Experimental evidence 
confirms cytokine- induced oxidative stress in rheumatoid synovium. Thioredoxin, a 
cellular catalyst induced by oxidative stress, is found in high amounts in RA synovial cells 
and tissue. Thioredoxin acts as a co- factor for tumor necrosis factor- alpha (TNF- - 
induced synthesis of interleukins (IL-6 and IL-8) in synovial fibroblastlike cells (Yoshida et 
al., 1999). Edaravone, which is a clinically available antioxidant, suppresses IL-1β- induced 
synovial cells proliferation and migration under in vitro conditions (Arii et al., 2006). N- 
acetylcytein, a known thiol antioxidant,  abrogated L-6 - induced proliferation of RA 
patients synovial fibroblasts (Ji-Yeon et al., 2000).  
ROS are documented as mediators of synovial inflammation. Excessive production of ROS 
at the site of inflammation contributes to the inflammatory process in general, by induction 
of the expression of adhesion molecules, pro-inflammatory cytokines, and chemoattractants. 
Furthermore, ROS can directly increase tissue destruction through inactivation of the major 
inhibitor of degrading enzymes, 1-antiproteinase, which subsequently leads to the 
activation of extracellular matrix-degrading metalloproteinases (MMPs) (Maurice et al., 
1997). 3-nitrotyrosine (3- NT) has been identified as a stable end product and marker of 
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inflammation and RNS production. Nitrated proteins are generated in inflamed tissues by 
inflammatory cells producing ONOO-, a naturally occurring nitrating agent. A study by 
Khan & Siddiqui (2006) further investigated the binding characteristics of naturally 
occurring antibodies to 3- NT present in synovial fluid. Antibodies to 3- NT were found 
higher in the synovial fluid of RA patients.    
Ex-vivo cultured rheumatoid synovium produces a significant amount of nitrite, and the 
addition of N- methylarginine (L-NMMA) significantly inhibits NO production. In vitro 
study revealed that NO production from freshly isolated synovial cells was up- regulated by 
stimulation with a combination of IL-1, TNF- and lipopolysaccharide. Inducible NOS 
expression was induced when human chondrocytes were stimulated with IL-1, TNF- or 
endotoxin in a dose- and time-dependent manner. Inflammatory reaction in the synovium 
of RA patients could be augmented by the autocrine or other cytokine-induced production 
of IL-6 with subsequent generation of ROS in the synoviocytes. Fibroblast- like synoviocytes 
proliferation by IL-6 was inhibited by N- acetylcysteine. Oxidative stress of RA synovial 
tissue can cause DNA damage and suppress the DNA mismatch repair (MMR) system in 
cultured synoviocytes. DNA MMR enzyme expression is greatest in the synovial intimal 
lining layer, where maximal oxidative stress in RA occurs (Šimelyte et al., 2004).  
4.2 Cycles of hypoxia/ reoxygenation in inflammatory synovium 
Angiogenesis in the synovial membrane is an important early step in pathogenesis of RA, in 
the perpetuation of the disease and may precede other pathological features. Elevated levels 
of pro-angiogenic factor, the vascular endothelial growth factor VEGF, are expressed in 
synovium, synovial fluids, and serum of RA patients. An increased VEGF level in RA is 
responsible for subsequent joint destruction. The synovium of RA is hypoxic as a result of 
synovial tissue proliferation outpacing in angiogenesis. Hypoxia is a potent inducer of 
cytokines, matrix degrading enzymes, angiogenic factors that play a central role in the 
inflammatory response. Hypoxia- inducible factor- 1 (HIF-1) is a key transcription factor 
which is highly inducible by hypoxia and expressed predominantly in synovium of RA. 
Expression of HIF-1 is critical for joint inflammation. RA synovial fluids are hypoxic, acidic 
with low glucose and elevated lactate concentrations. This biochemical profile is indicative 
of a chronically hypoxic microenvironment that compensates by anaerobic metabolism. The 
oxygen partial pressure (pO2) is extremely low in RA synovial fluids, and correlates with 
elevated plasma levels of lactate. Inflamed synovitis is a hallmark of RA which is hypoxic in 
nature (Shankar et al., 2009). The biological basis of this process relates to hypoxia- inducible 
factor (HIF). The response of mammalian cells to hypoxia is mediated partly through 
stabilization of certain transcription factors including HIF-1 and HIF-2.  These oxygen 
sensitive transcription factors are multifunctional. Firstly, they program the cells to 
anaerobic metabolism, secondly, they enhance cell survival by inhibiting apoptosis, and 
thirdly they improve the supply of oxygen by promoting angiogenesis and increase oxygen- 
carrying capacity. In view of the crucial role of HIF-1 in cellular adaptation to hypoxia, its 
regulation needs to be rapidly responsive to changes in the cellular oxygen supply. 
Inhibition of degradation is the primary mechanism by which hypoxia directly regulates 
HIF- 1. In the absence of oxygen critical step of degradation process of HIF-1, the 
hydroxylation of proline and asparagine residues, becomes rate limiting, thus preventing 
HIF-1 from being degraded and leaving it free to bind to its constitutively expressed 
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partner HIF-1β. In rheumatic patients, joint movement in a ratio of normally functional joint 
increases the pO2 leading to re-oxygenation. In RA cycling transient episodes of hypoxia/re- 
oxygenation increase levels of ROS. Increased mitochondrial ROS levels stabilize the 
transcription factor HIF- 1 (Chandel et al., 2000). Of particular relevance to RA was the 
marked attenuation of synovitis and articular damage in an adjuvant arthritis model when 
HIF- 1 was absent. In RA synovitis, HIF-1a protein accumulates and translocates to the 
nucleus and directly activates transcription of pro-angiogenic factor like VEGF.  VEGF is 
highly inducible by hypoxia which occurs in the inflamed joints of RA. The HIF-1 
translocates and binds to core DNA motif in the hypoxia responsive elements (HRE) which 
are associated with target genes such as VEGF and induces its gene expression and thereby 
angiogenesis. HIF-1 is expressed abundantly by macrophages in most rheumatoid synovia, 
predominantly close to the intimal layer but also in the subintimal zone (Hollander et al., 
2001).  The synovial expression of HIF-1 also showed a mixed nuclear and cytoplasmic 
pattern mostly seen in lining cells, stromal cells, mononuclear cells, and blood vessels 
(Giatromanolaki et al., 2002). The number of HIF-1 -positive cells correlated strongly with 
the number of blood vessels in RA synovial tissue and with inflammatory endothelial cell 
infiltration (blood vessels), cell proliferation (Ki67) and the synovitis score (Brouwer et al., 
2009). Reduction in the degradation rate of HIFs (HIF-1, and HIF-2) as occurs under 
hypoxic stress throughout arthritis, results in increased steady- state level of HIFs proteins 
and up-regulation of the neo- angiogenic process. Neo-angiogenic VEGF/ KDR pathway 
was shown persistently increased in RA, as indeed was microvessel density and the 
expression of PD- ECGF, irrespective of the extent of HIF expression (Giatromanolaki et al., 
2002). The direct link exists between accumulation of HIFs and overexpression of VEGF in 
RA. Neo-angiogenesis contributes to pathogenesis of RA encouraging synovitis, pannus 
formation and articular cartilage destruction. Concluding, the HIF seems to be a promising 
factor that targets both synovitis and angiogenesis in RA.   
5. Oxidative stress in human autoimmune joint diseases 
5.1 Rheumatoid arthritis 
Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory disease primarily 
affecting synovial membranes of joints. Pathogenesis of RA is a multistep process where 
cellular and humoral interactions mediated by lymphocytes (T and B cells) and non 
hematopoietic cells like fibroblasts, connective tissue cells, and bone cells play a role. At site 
of inflammation, activation of T cells and macrophages leads to a large increase in oxygen 
consumption, whose corollary is increased release of ROS (Afonso et al., 2007). Both, 
hematopoietic, and connective tissue cells are subject of oxidative stress process in arthritis.  
5.1.1 Hematopoietic cells and tissue as oxidative stress targets in RA 
Activity of NADPH- oxidase is enhanced in circulating neutrophils and monocytes of RA 
patients. These phagocytic cells synthesize two- to eight- fold higher amounts of O2_ when 
compared to healthy controls. Production rates of O2_ in neutrophils and monocytes from 
rheumatic patients positively correlate with the plasma levels of TNF-  (Miesel et al., 1996). 
Other parameters of oxidative stress like decrease in neutrophil SOD activity and an 
increase in the levels of “loose” iron in the plasmalemma of RA neutrophils and monocytes 
www.intechopen.com
 
Oxidative Stress and Diseases 
 
444 
were also observed (Ostrakhovitch  Afanas´ev, 2001). A characteristic feature of RA ROS- 
producing neutrophils is their functional state. The production of O2_ by blood neutrophils 
from RA patients in response to N-formyl-methionylleucyl-phenylalanine, a stimulatory 
agent, was greater in arthritic than control blood neutrophils (Eggleton et al., 1995). The 
study suggested that stimulated sub-population of neutrophils are source of ROS in 
arthritis.   
5.1.2 Connective cells and tissue as oxidative stress targets in RA  
Studies of RA synovial fluid (SF) and tissue have demonstrated oxidative damage to the 
tissue. Signs of oxidative stress such as DNA oxidative damage, and lipid peroxidation are 
present in the inflammatory synovium of RA patients. Immunohistochemical analysis 
revealed increased staining of 8- oxo- 7,8- dihydro- 2´- deoxyguanine, a marker of DNA 
oxidative damage, and increased staining of 4-hydroxy-2-nonenal in the lining and 
sublining layers of the RA inflammatory synovium (Šimelyte et al., 2004). Furthermore, it 
was shown that increased lipid peroxidation damage in RA inflammatory synovium is 
proportional to the levels of hypoxia in the joint, disease activity and angiogenic marker 
expression (Biniecka et al., 2009). Synovial fluids macrophages produce increased amounts 
of O2_. Also neutrophils from synovial fluids of rheumatic patients generate increased 
amounts of  O2_ possibly because of their exposure to cytokines present in synovial fluids 
(Hitchon  El-Gabalawy, 2004). Chronic oxidative stress contributes to functional 
hyporesponsiveness of synovial T lymphocytes. The impaired mitogenic responses of SF T 
lymphocytes correlated with a significant decrease in the levels of the intracellular redox-
regulating agent glutathione (GSH) (Maurice et al., 1997).   
Indirect evidence for ROS implication in cartilage degradation comes from the presence of 
lipid peroxidation products, nitrite, nitrotyrosine, a nitrated type II collagen peptide, modified 
low-density lipoprotein (LDL) and oxidized IgG in the biological fluids of patients with 
arthritis. Furthermore, nitrotyrosine, nitrated proteins and oxidized LDL (ox-LDL) have been 
found to be accumulated in cartilage of arthritic patients demonstrating the direct implication 
of ROS in some joint diseases. Rheumatoid arthritis is characterized by irreversible damage to 
the cartilage matrix caused by enzymatic degradation of the proteins, e.g., collagen type II 
(CII), and proteoglycans of cartilage (e.g., aggrecan) (Billinghurst et al., 1997). As a result of the 
breakdown of the proteins and proteoglycans, CII degradation products and sulfated 
glycosaminoglycans (GAGs) appear in SFs of the affected joints. The level of GAGs in SF 
indicates the extent of proteoglycan degradation (Lark et al., 1997). Hydrogene peroxide, and 
singlet oxygen accelerate bone resorption by osteoclasts. Osteoclasts generate ROS through 
ˮNADPH- oxidase dependent mechanismsˮ. Studies involving assays of nitrotyrosine residues 
in synovial tissues from patients with RA or exposure of chondrocytes to synthetic 
peroxynitrite in vitro have established that combination of the O2.- anion to nitric oxide (NO) 
causes cartilage damage (Abramson et al., 2001).  
The cytokine network is involved in the pathogenesis of RA. IL-1 is a key mediator of bone 
resorption and cartilage destruction in arthritis. The cytokine activates bone resorption 
through its effects on osteoclast differentiation and activation. IL-1 destructs cartilage by 
stimulating release of MMPs from fibroblasts and chondrocytes. Neutralizing ROS activity 
significantly attenuated IL-1- induced collagenase gene expression in bovine chondrocytes 
(Lo et al., 1998).  
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In RA oxidative stress also features by oxidation of low- density lipoproteins (LDL). 
Oxidized LDLs promote inflammatory changes including local up- regulation of adhesion 
molecules and chemokines.  
RA tissue has evidence of microsatellite instability reflecting ongoing mutagenesis. Such 
mutagenesis is normally corrected by DNA repair systems including the mismatch repair 
system, which is defective in RA, probably due to oxidative stress.   
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Fig. 1. Connective tissue and cells as targets of oxidative stress in rheumatoid arthritis. 
6. Systemic lupus erythematosus 
Systemic lupus erythematosus (SLE) is a prototype autoimmune, multisystem and 
multifactorial disease characterized by the presence of auto-antibodies to a variety of 
nuclear antigens such as DNA and histones, as well as protein antigens and protein–nucleic 
acid complexes. The initial immunizing antigen(s) that drive the development of SLE are 
unknown, but characteristics of the immune response in SLE suggest that it is an antigen-
driven condition. Multiorgan inflammatory lesions also involve the joints. Immune complex 
deposits in the synovium are associated with mild inflammation and cartilage destruction is 
seldom severe. The arthritis of SLE is described as non-destructive and non-deforming. 
Immune complex deposits in the synovium trigger inflammatory reaction, which led 
continuously to cartilage destruction (Khan  Siddiqui, 2006). Free radicals synthesize 
autoantigens, which contribute to disease development. Oxidative stress and inflammation 
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are interrelated in SLE. Malondialdehyd (MDA) levels positively correlated with levels of 
interferon-  (INF-), and interleukin- 12 (IL- 12) in lupus disease (Shah et al., 2010).  
6.1 Hematopoietic cells and tissue as oxidative stress targets in SLE 
Oxidative damage to red blood cells and leukocytes are hallmarks of oxidative stress in SLE. 
Lipid peroxidation, in SLE erythrocytes, and generation of O2.- and H2O2 in leukocytes were 
increased in SLE patients when compared to healthy controls (Tewthanom et al., 2008). 
Destroying effects of free radicals in lupus disease are apparent on the reactions with serum 
proteins. Oxidation makes the proteins more fragile. Modified proteins become 
autoantigens, and more, their presence enhances oxidative stress in serum. 4-hydroxy-2-
nonenal (4- HNE), which is a marker of lipid peroxidation in SLE, after binding protein 
forms dangerous protein adducts. The target of 4- HNE modification reported was catalase, 
a membrane protein of red blood cells (D’Souza et al., 2008). Hydroxyl radical binds human 
serum albumin. The increase in total serum protein carbonyl levels in the SLE patients was 
largely due to an increase in oxidized albumin (Shjekh et al., 2007).  
In lupus disease, oxidative stress presents by lipid peroxidation mostly. Moreover it was 
discovered that lipid peroxidation influences pathogenesis of the disease. The disease 
activity score (SLEDAI) positively correlates with serum levels of MDA. T-lymphocyte 
apoptosis and MDA were positively associated with disease activity (Shah et al., 2011). 
MDA- modified proteins as the catalase, and SOD are targets of IgG circulated 
autoantibodies promoting disease development. On the other hand, SLEDAI score correlates 
negatively with serum antioxidant enzymes as SOD, and glutathione peroxidase (GPx) 
(Taysi et al., 2002 b). Auto- antibodies against plasma lipoproteins have been reported in 
SLE patients (Batuca et al., 2007).  The study further documented incidence of antibodies 
toward high density lipoproteins (HDL) in patients with SLE, and identified Apo A-I as a 
target of oxidative damage. The incidence of auto-antibodies against lipid particles 
correlated with reduced activity of paraoxonase (PON), which is the most active antioxidant 
enzyme in lipids, and also prevents lipid peroxidation of low density lipoproteins (LDL). 
6.2 Connective cells and tissue as oxidative stress targets in SLE 
The arthritis of SLE is described as non- destructive and non- deforming. Immune complex 
deposits in the synovium are associated with mild inflammation and cartilage destruction is 
seldom severe. In SLE patients, NO and its intermediates may be mediators of inflammatory 
arthritis. Antibodies against 3- nitrotyrosine (3- NT) were found elevated in sera, and 
synovial fluid of SLE patients. Interestingly, the sera levels were much higher than in 
synovial fluid (Khan & Siddiqui, 2006).   
7. Markers of oxidative stress in human autoimmune joint diseases 
A short lifetime of free radicals in body fluids restricts their direct estimation instead effects 
of oxygen on lipids, proteins, and nucleic acids molecules are used. There are many 
chemical modifiers of protein, and lipid structures, whose activity is accelerated by 
oxidative stress. N-carboxymethyllysine (CML) represents a chemically modified amino acid 
and originates in vivo from carbohydrate as well as from lipid derived precursors. Oxidative 
damage to proteins is also reflected by increased levels of advanced oxidation protein 
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products (AOPP), which form by the reaction between chlorinated oxidants (HOCl/OCl_) 
and proteins. AOPP are defined as dityrosine-containing cross-linked proteins. MDA is one 
of the end products of lipid peroxidation induced by ROS and marker of oxidative stress in 
lipids. 8-Hydroxy-2´-deoxyguanosine (8-OHdG) has been recognized as a biomarker of 
oxidative DNA damage by endogenously generated oxygen radicals. In addition, oxidative 
stress may be estimated by levels of enzymes like thioredoxin, a protein with reduction / 
oxidation active disulfide / dithiol groups in its active site. Signs of oxidative stress are 
apparent on cells and tissue affected by arthritis. Advanced glycation end products (AGEs), 
which are formed during the Maillard reaction by non-enzymatic glycation, and oxidation 
of proteins were detected in the synovial lining, sublining, and endothelium in RA patiens. 
CML showed positive immunostaining in some RA macrophages (CD68+) and T cells 
(CD45RO+) (Drinda et al., 2002). High levels of protein carbonyl (PCO), and AGE products 
were found in serum of collagen – induced arthritis mice (Choi, 2007). Plasma MDA 
concentrations are significantly higher in RA patients (Sarban et al., 2005). An excessive 
degree of oxidative stress in RA patients confirm decline of protein thiol levels and lower 
activity of antioxidant enzymes like glutathione (GSH), GPx, and CuZn SOD in blood of 
these patients (Seven et al., 2008). The study by Jikimoto (Jikimoto et al., 2001) discovered 
elevated levels of TRX in plasma, and synovial fluid of RA patients. Plasma TRX correlated 
with urinary excretion of  8-hydroxy-29-deoxyguanosine (8-OHdG). Serum MDA levels 
were increased in SLE patients, while serum antioxidant levels were decreased in these 
patients what confirms oxidative stress in the pathology of SLE (Taysi et al., 2002 a).   
8. Oxidative stress in autoimmune joint diseases: Beneficial or harmful? 
The recent research describes dual role of ROS in autoimmune- joint diseases. The ROS 
production by the activated NOX- family (NADPH) of oxidases has a principal function 
throughout the priming phase of the development of autoimmune joint diseases. The 
NADPH oxidase- deficient knockout mice developed a serious inflammatory arthritis with 
extensive bone erosions and a massive osteolysis (van de Loo et al., 2003).  ROS might 
reduce arthritis development influencing circulating inflammatory cells before they reach 
the joint. ROS limit T cell responses to self- antigens inducing their apoptosis, what inhibits 
disease development (Olofsson et al., 2003). Arthritis development correlates with 
functionality of NADPH- oxidase complex, which is determined by the neutrophil cytosolic 
factor 1 (Ncf 1), a phagocytic oxidase. The naturally occurring polymorphism of Ncf1 allele 
limiting the NADPH functionality promotes activation of arthritogenic CD4+ cells. An 
expansion of arthritogenic T cells owing to the lower activity of the NADPH- oxidase 
complex was observed in the DA Ncf 1 allele (Olofsson et al., 2003). An increased severity of 
arthritis was observed in animals with either loss of function mutations or deletions in 
components of the phagocyte NADPH- oxidase like the p47phox (van de Loo et al., 2003). 
Furthermore, the effect of NOX-derived ROS might depend on the arthritis model: in IFN- 
gamma (INF- ) enhanced imine complex arthritis, the p47phox-deficient animals showed a 
less severe joint destruction and decreased chondrocyte death (Lem van Lent et al., 2005). 
The NADPH- oxidase- derived superoxide is not exclusive effector molecule in arthritis. 
Superoxide dismuthase (SOD) catalyses the dismutation of superoxide anion to oxygen and 
hydrogen peroxide. Three SOD enzyme isoforms have been characterized in humans. SOD 
I, and SOD III are copper, zinc, enzyme isoforms.  SOD II is a manganese enzyme isoform. 
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Whereas type I SOD is found mostly in the cytoplasm, nucleus, and intermembrane space of 
mitochondria, type III of SOD is extracellular. Manganese is cofactor for SOD type II, which 
is a mitochondrial enzyme. The enzyme is involved in the pathogenesis of inflammatory 
joint disease. In adjuvant model of arthritis the enzyme suppressed swelling, and retarded 
bone destruction (Shingu et al., 1994). An intra-articular injection of SOD significantly 
reduced synovitis in streptococcal wall cell (SWC)- model of arthritis. Intra- aricular 
injection of native SOD (bovine orgotein) produced greater clinical improvements than did 
intra- articular aspirin in patients with RA involving the knee (Afonso et al., 2007). Available 
data suggest a protective role of SOD in inflammatory joint disease. In mice that are 
genetically deficient in SOD III, both the severity of collagen-induced arthritis and the 
production of pro-inflammatory cytokines are increased. SODIII gene transferred 
subcutaneously or intra- articularly decreased the severity of experimental arthritis in 
rodents. 
9. Antioxidants as therapeutic possibilities in human autoimmune joint 
diseases 
9.1 Antioxidant enzymes 
SODs exert protective effects in animal models of inflammation. In mice, genetically 
deficient in SOD III, both the severity of collagen- induced arthritis and the production of 
pro- inflammatory cytokines are increased (Ross et al., 2004). SOD III gene transfer into the 
knee decreased the severity of experimental arthritis in rodents. In humans, serum SOD III 
levels correlated negatively with disease activity. Despite conflicting results of native SOD 
(orgotein) in RA patients, SOD mimetics have shown beneficial effects. Until now, the most 
promising are nitroxide (tempol) and Mn (II) pentaazamacrocyclic ligand (M40403). In vitro, 
tempol diminishes hydroxyl radical production, and decreases the cytotoxic effects of 
hydrogen peroxide and peroxynitrite. Tempol decreased collagen- induced arthritis in rats 
(Cuzzocrea et al., 2001). The anti-inflammatory effects of M40403 ligand are related to 
superoxide elimination, and restraint of nitration of tyrosine residues in proteins. M40403 
ligand diminishes the expression of adhesion molecules such as integrins or selectins 
decreasing influx of neutrophils to inflammatory site. M40403 ligand inhibits TNF- via 
blocking the nuclear factor kappa B (NF- B). Its beneficial effects have been reported in rats 
with collagen- induced arthritis (Cuzzocrea et al., 2005).  
9.2 Vitamins 
Micronutrient supplementation has been recommended to arthritic patients based on 
findings that the antioxidant status is very low in these patients. It has been documented 
that the mean synovial fluid concentrations of α-tocopherol are significantly decreased in 
arthritic patients compared to healthy controls. Also, levels of vitamin E in peripheral blood 
cell were significantly decreased in patients with active arthritis than in healthy subjects 
(Vasanthi et al., 2009). Concentrations of other antioxidant vitamins such as A, C are of 
lower order in RA and SLE patients than in normal subjects too. Based on animal studies, 
there is evidence that antioxidant vitamins may prevent arthritis, and increase antioxidant 
status. Daily oral administration of vitamin E to male arthritic rats restored levels of thiol (-
SH) groups to pre- arthritic levels (Kheir- Eldin et al., 1992). High doses of vitamin C (1-
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2g/kg body weight) applied to arthritic Lewis rats, delayed incidence of paw oedema in 
these rats. Histological studies revealed a decreased inflammatory cells infiltration of 
superficial layer of synovium, and decreased synovial SOD activity in these rats (Sakai et al., 
1999). In addition, administration of rutin (vitamin P) strongly inhibited spontaneous ROS 
production in RA neutrophils (Ostrakhovitch  Afanas´ev, 2001). Vitamin E exerts analgetic 
effects. The results from a double blind clinical trials suggested that a dose of 400–1200 mg 
of -tocopherol daily was effective with respect to various pain parameters such as pain on 
pressure, pain at rest, and pain on movement. The postulated analgesic properties of 
vitamin E seem to be correlated to vitamin E plasma concentrations. Patients with active RA 
supplemented with a combination of conjugated fatty acids and vitamin E improved their 
disease activity score. The diet in these patients relieved from night and activity pain, and 
morning stiffness (Aryaeian et al., 2009). The analgesic effect of vitamin E is independent of 
a peripheral anti-inflammatory action, thereby suggesting a central rather than peripheral 
action. Dietary antioxidant micronutrients act as scavengers of reactive oxygen radicals and 
may protect against free radical mediated tissue damage in an inflamed joint. Vitamin E 
supplemented in soyabean oil reduced anti- double- stranded DNA IgG antibodies (Chia- 
Chien  Bi- Fong, 2005).  
9.3 Fatty acids 
Eicosapentaenoic acid and docosahexaenoic acid (EPA and DHA respectively) exert potent 
antioxidant properties. Supplementation with these acids to lupus patients restored levels of 
antioxidant enzymes as the GPx, and SOD to baseline levels (Mohan,  Das, 1997). Lupus 
autoimmune female mice fed with fish oil exhibited significantly higher liver of catalase, 
SOD, and GPx. The diet was shown to be beneficial against oxidative damage of hepatic 
tissue (Bhattacharya et al., 2003). Sera of lupus mice treated with conjugated linoleic acid 
(CLA) contained higher concentrations of total GSH which were negatively correlated with 
the levels of oxidative stress markers. Moreover, increased GSH, gammaGCL, glutathione S-
transferase (GSTs), and NAD(P)H:quinone oxidoreductase (NQO1) activities were 
measured in liver and spleen of CLA-treated animals. The activation of detoxifying enzymes 
may be one of the mechanisms whereby dietary CLA down-regulates oxidative stress in 
lupus mice (Bergamo et al., 2007). 
10. Conclusions and future perspectives 
In all cell types, oxygen metabolism can lead to the production of reactive oxygen / nitrogen 
species. Reactive species are known for their dual role as both beneficial and harmful. 
Deleterious effects of oxidative stress on cell components (proteins, lipids, DNA) include 
changes in their structure, and function. On the other hand, beneficial effects of ROS/RNS 
involve physiological cellular responses to noxious agents, e.g., in defense against infectious 
agents, in a number of cellular signaling pathways and in the induction of a mitogenic 
response. Oxidants even protect cells against oxidative stress and re-establish or maintain 
redox homeostasis (Ortona et al., 2008).  
Oxygen metabolism has an important role in the pathogenesis of autoimmune joint diseases. 
Reactive oxygen/nitrogen species are documented as mediators of synovial inflammation. 
Their excessive production at the site of inflammation contributes to inflammatory process 
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in general, by induction of local production of chemoattractants, adhesion molecules, and 
pro- inflammatory cytokines. In addition, oxidative stress may contribute to the cyclic, self- 
perpetuating nature of autoimmune inflammation. Immune cells when “affected” by 
oxidants became auto- antigens intensifying auto- immune responses. Persisting auto-
inflammation, and oxidative stress in joint area leads to damages of connective tissue and 
the ECM directly or indirectly. In vitro, lipid peroxidation, ONOO- formation is associated 
with decreased production of type II collagen and aggrecan, and with diminished 
chondrocyte responses to growth factors. Moreover, ONOO- interferes with metabolism of 
matrix enhancing the expression of matrix degrading enzymes inhibiting the production 
and activity of tissue inhibiting enzymes. Hydrogen peroxide and singlet oxygen accelerate 
bone resorption. Level of oxidative stress in rheumatoid synovium is proportional to the 
levels of hypoxia and angiogenesis in the joint area.  
Oxidative stress generated within an inflammatory joint can produce autoimmune 
phenomena and connective tissue destruction in rheumatoid synovitis (Vasanthi et al., 
2009). Swelling stiffness pain in rest immobility are common symptoms of autoimmune joint 
diseases. Rationale of antioxidant therapy should relieve from objective complications. 
Polyunsaturated fatty acids (PUFA) can modulate oxidative stress and may have a role as 
regulators in the synthesis of antioxidant enzymes (Mohan  Das, 1997). Arthritic patients 
taking these acids showed biochemical and chemical improvement. Dietary 
supplementation significantly decreased joint pain index. In combination with other dietary 
modifications modest improvement in morning stiffness and in the number of painful joints 
were reported. Clinical improvements were connected with anti- inflammatory effects as a 
decreased synthesis of leukotriens by neutrophils and lower synthesis of IL-1 by 
macrophages. Significant clinical benefit has been claimed in SLE patients given a low- fat 
diet with PUFA (reviewed in Darlington  Stone, 2001). The clinical work with diets 
containing PUFA has clearly demonstrated their anti-inflammatory effects, but it was also 
shown that these effects were attributed to omega- 3 (-3) rather than -6 PUFA. As there is 
no doubt about dietary fatty acids do decrease the generation of inflammatory agents, 
opposite results have been obtained on free radical formation. PUFA are especially potent at 
increasing levels of oxidative stress. On the other hand, EPA increases mitochondrial Mn- 
SOD mitochondrial activity.  
The hypothesis about oxidative stress promotes arthritic process was challenged when 
oxidants were shown to decrease disease severity in mouse and rat arthritis models. Certain 
oils with an alkane structure such as phytol besides its oxidative effects protect against 
arthritis development. Its subcutaneous administration prevented development of pristane- 
induced arthritis (Hultqvist et al., 2006). Rats treated with phytol in acute phases of pristane 
arthritis showed no signs of inflammation. A decrease in COMP, a measurement of ongoing 
cartilage destruction, was prevented during chronic phases of the disease. The efficiency of 
phytol in preventing arthritis was compared to methotrexate and/or etanecerpt.  Etanecerpt, 
TNF- blocker, was highly effective in reducing collagen- induced arthritis. In pristane- 
induced arthritis, the preventive effects of phytol was more pronounced than that of 
etanecerpt.  Also, in comparison to MTX, phytol was valid as a potential therapeutic agent. 
Concluded, ROS-promoting substances such as phytol represent a promising class of 
therapeutics for treatment of autoimmune joint inflammatory diseases what needs further 
research. 
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